Ledger.Open graph →
SEC Form D · filed April 23, 2014

Corbus Pharmaceuticals Holdings, Inc

Offering
$13.0M
Sold
$6.3M
Exemption
Rule 506(b)
Industry
Investing
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Carsten D. Koppen · St Helier, Y9ExecYuval Cohen · Bethesda, MDExec · DirectorStewart N. Cleveland · George Town, Grand Cayman, Cayman IslandsDirectorS. C. Honig · San Mateo, CAExecRobert Zurier · Wyckoff, NJExecYuval Cohen · New York, NYExec · DirectorAlan Holmer · Farmingham, MADirectorSean Moran · Pittsburgh, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗